News
Confirms cost-reduction plans as part of an 'operational excellence' initiative
Gains indication as an add-on treatment for serious depressive episodes
Regulators green-light anti-psychotic Sycrest and cardiovascular drug Brinavess
This week's roundup of CRO news includes updates from Cyprotex, INC Research, Laxai Pharma and Epistem
Study of weight-loss drug published in the New England Journal of Medicine
Biotech's chief executive wants Sanofi to recognise his company’s strategic value
Boosts rare diseases portfolio with purchase of US drug discovery company FoldRx
Festival themed site for UK teenagers with haemophilia offers innovative entry sequence
EMA hands Transgene positive opinion for immunotherapy drug study
